Cansu Sarıkaya1, Gülçin Gacar2, Hüsnü Efendi3

  • 1Department of Neurology, Maltepe University Faculty of Medicine, Istanbul, TUR.

Cureus
|November 4, 2024
PubMed
概括

芬戈利莫德治疗显著降低了复发性复发性多发性硬化症 (RRMS) 患者的B淋巴细胞数量. 这表明fingolimod对B和T淋巴细胞都有影响,提供了比以前理解的更广泛的作用机制.